According to the new market research report, “API Contract Manufacturing Market, by Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022”, the global active pharmaceutical ingredient (API) contract manufacturing market was expected to be worth USD 66.54 billion in 2016 and is anticipated to reach USD 103.40 billion by 2022, growing at a CAGR of 7.6% from 2016 to 2022.
Chicago, IL -- (SBWIRE) -- 03/08/2017 -- The global API contract manufacturing market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.
Browse Report Summary: https://www.scalarmarketresearch.com/market-reports/api-contract-manufacturing-market
Early buyers will receive 10% free customization on this report.
Key findings of the report:
The easy access to resources and the advanced products is one of the significant driving factors for the global active pharmaceutical ingredient (API) contract manufacturing market, during the forecast period.
The availability of inexpensive labor across the emerging markets and the demand to hasten the process of drug discovery are also expected to be some of the major drivers for the API contract manufacturing market.
The rapid advancements and the reduced time-to-market process are also expected to provide major growth opportunities to this market during the forecast period.
The emerging markets are expected to witness rapid growth in the market
According to the report, the emerging markets such as Asia-Pacific, Latin America, and Middle East & Africa are expected to witness rapid growth during the forecast period. According to the report, the regions like North America and Europe are expected to dominate the global market based on the overall market share, during the forecast period.
Request Sample: https://www.scalarmarketresearch.com/request-sample.php?id=211
The key players highlighted in the API contract manufacturing market report include:
1. Teva Pharmaceutical Industries, Ltd
2. Sun Pharmaceutical Industries Ltd
3. Dr.Reddy's Laboratories
4. Aurobindo Pharma Ltd
5. Mylan N.V
6. Novartis AG
7. Cambrex Corporation
8. Boehringer Ingelheim GmbH
9. Pfizer, Inc
10. Lonza Group
11. About Scalar Market Research
Scalar Market Research, Inc., a U.S.-based market research and consulting firm, assists organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.
Find out more about our services at: www.scalarmarketresearch.com
Contact:
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Email: sales@scalarmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/scalar-market-research